An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1

Dopamine D 2 and D 3 receptors are similar subtypes with distinct interactions with arrestins; the D 3 receptor mediates less agonist-induced translocation of arrestins than the D 2 receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intrac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2009-01, Vol.75 (1), p.19-26
Hauptverfasser: Lan, Hongxiang, Teeter, Martha M., Gurevich, Vsevolod V., Neve, Kim A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 26
container_issue 1
container_start_page 19
container_title Molecular pharmacology
container_volume 75
creator Lan, Hongxiang
Teeter, Martha M.
Gurevich, Vsevolod V.
Neve, Kim A.
description Dopamine D 2 and D 3 receptors are similar subtypes with distinct interactions with arrestins; the D 3 receptor mediates less agonist-induced translocation of arrestins than the D 2 receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D 2 and D 3 receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin3 bound to glutathione transferase (GST) fusion proteins of the D 2 receptor IC2 more avidly than to the D 3 receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin3 to D 2 -IC2; arrestin binding to D 2 -IC2-K149C was greatly decreased compared with wild-type D 2 -IC2, whereas binding to the reciprocal mutant D 3 -IC2-C147K was enhanced compared with wild-type D 3 -IC2. Mutating this lysine in the full-length D 2 receptor to cysteine decreased the ability of the D 2 receptor to mediate agonist-induced arrestin3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D 3 receptor increased receptor-mediated translocation of arrestin3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D 2 receptor over the D 3 receptor is due in part to Lys149, which could be exposed as a result of receptor activation.
doi_str_mv 10.1124/mol.108.050542
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2606909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_2606909</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_26069093</originalsourceid><addsrcrecordid>eNqljk1LxDAURYMoTv3Yun5_oPW9TFvajVCtouBKXLgrsX2diaRJSVJB_PN2wI1rVxfu5RyuEFeEGZHMrydnMsIqwwKLXB6JhApJKRLRsUgQZZlWdfG2EWchfCBSXlR4KjZUVRJJlon4biw82ehVz8YsRnl4dm4GCc2krYOm1wO8cNDDwtByZL_WHKDV48iebdTKwK22g7Y7cCM03nOI2kJ0EPcr4mZ1IKCVoOwA7Xa19TxH5wNdiJNRmcCXv3kubh7uX-8e03l5n3jo-fDLdLPXk_JfnVO6-7tYve927rOTJZY11tt_C34A-nxr7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Lan, Hongxiang ; Teeter, Martha M. ; Gurevich, Vsevolod V. ; Neve, Kim A.</creator><creatorcontrib>Lan, Hongxiang ; Teeter, Martha M. ; Gurevich, Vsevolod V. ; Neve, Kim A.</creatorcontrib><description>Dopamine D 2 and D 3 receptors are similar subtypes with distinct interactions with arrestins; the D 3 receptor mediates less agonist-induced translocation of arrestins than the D 2 receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D 2 and D 3 receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin3 bound to glutathione transferase (GST) fusion proteins of the D 2 receptor IC2 more avidly than to the D 3 receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin3 to D 2 -IC2; arrestin binding to D 2 -IC2-K149C was greatly decreased compared with wild-type D 2 -IC2, whereas binding to the reciprocal mutant D 3 -IC2-C147K was enhanced compared with wild-type D 3 -IC2. Mutating this lysine in the full-length D 2 receptor to cysteine decreased the ability of the D 2 receptor to mediate agonist-induced arrestin3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D 3 receptor increased receptor-mediated translocation of arrestin3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D 2 receptor over the D 3 receptor is due in part to Lys149, which could be exposed as a result of receptor activation.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.108.050542</identifier><identifier>PMID: 18820126</identifier><language>eng</language><publisher>American Society for Pharmacology and Experimental Therapeutics</publisher><ispartof>Molecular pharmacology, 2009-01, Vol.75 (1), p.19-26</ispartof><rights>U.S. Government work not protected by U.S. copyright</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Lan, Hongxiang</creatorcontrib><creatorcontrib>Teeter, Martha M.</creatorcontrib><creatorcontrib>Gurevich, Vsevolod V.</creatorcontrib><creatorcontrib>Neve, Kim A.</creatorcontrib><title>An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1</title><title>Molecular pharmacology</title><description>Dopamine D 2 and D 3 receptors are similar subtypes with distinct interactions with arrestins; the D 3 receptor mediates less agonist-induced translocation of arrestins than the D 2 receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D 2 and D 3 receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin3 bound to glutathione transferase (GST) fusion proteins of the D 2 receptor IC2 more avidly than to the D 3 receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin3 to D 2 -IC2; arrestin binding to D 2 -IC2-K149C was greatly decreased compared with wild-type D 2 -IC2, whereas binding to the reciprocal mutant D 3 -IC2-C147K was enhanced compared with wild-type D 3 -IC2. Mutating this lysine in the full-length D 2 receptor to cysteine decreased the ability of the D 2 receptor to mediate agonist-induced arrestin3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D 3 receptor increased receptor-mediated translocation of arrestin3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D 2 receptor over the D 3 receptor is due in part to Lys149, which could be exposed as a result of receptor activation.</description><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqljk1LxDAURYMoTv3Yun5_oPW9TFvajVCtouBKXLgrsX2diaRJSVJB_PN2wI1rVxfu5RyuEFeEGZHMrydnMsIqwwKLXB6JhApJKRLRsUgQZZlWdfG2EWchfCBSXlR4KjZUVRJJlon4biw82ehVz8YsRnl4dm4GCc2krYOm1wO8cNDDwtByZL_WHKDV48iebdTKwK22g7Y7cCM03nOI2kJ0EPcr4mZ1IKCVoOwA7Xa19TxH5wNdiJNRmcCXv3kubh7uX-8e03l5n3jo-fDLdLPXk_JfnVO6-7tYve927rOTJZY11tt_C34A-nxr7Q</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Lan, Hongxiang</creator><creator>Teeter, Martha M.</creator><creator>Gurevich, Vsevolod V.</creator><creator>Neve, Kim A.</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>5PM</scope></search><sort><creationdate>20090101</creationdate><title>An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1</title><author>Lan, Hongxiang ; Teeter, Martha M. ; Gurevich, Vsevolod V. ; Neve, Kim A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_26069093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lan, Hongxiang</creatorcontrib><creatorcontrib>Teeter, Martha M.</creatorcontrib><creatorcontrib>Gurevich, Vsevolod V.</creatorcontrib><creatorcontrib>Neve, Kim A.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lan, Hongxiang</au><au>Teeter, Martha M.</au><au>Gurevich, Vsevolod V.</au><au>Neve, Kim A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1</atitle><jtitle>Molecular pharmacology</jtitle><date>2009-01-01</date><risdate>2009</risdate><volume>75</volume><issue>1</issue><spage>19</spage><epage>26</epage><pages>19-26</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>Dopamine D 2 and D 3 receptors are similar subtypes with distinct interactions with arrestins; the D 3 receptor mediates less agonist-induced translocation of arrestins than the D 2 receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D 2 and D 3 receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin3 bound to glutathione transferase (GST) fusion proteins of the D 2 receptor IC2 more avidly than to the D 3 receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin3 to D 2 -IC2; arrestin binding to D 2 -IC2-K149C was greatly decreased compared with wild-type D 2 -IC2, whereas binding to the reciprocal mutant D 3 -IC2-C147K was enhanced compared with wild-type D 3 -IC2. Mutating this lysine in the full-length D 2 receptor to cysteine decreased the ability of the D 2 receptor to mediate agonist-induced arrestin3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D 3 receptor increased receptor-mediated translocation of arrestin3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D 2 receptor over the D 3 receptor is due in part to Lys149, which could be exposed as a result of receptor activation.</abstract><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>18820126</pmid><doi>10.1124/mol.108.050542</doi></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2009-01, Vol.75 (1), p.19-26
issn 0026-895X
1521-0111
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2606909
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
title An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A54%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Intracellular%20Loop%202%20Amino%20Acid%20Residue%20Determines%20Differential%20Binding%20of%20Arrestin%20to%20the%20Dopamine%20D2%20and%20D3%20Receptors1&rft.jtitle=Molecular%20pharmacology&rft.au=Lan,%20Hongxiang&rft.date=2009-01-01&rft.volume=75&rft.issue=1&rft.spage=19&rft.epage=26&rft.pages=19-26&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.108.050542&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_2606909%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18820126&rfr_iscdi=true